1. Recent clinical advances in lung cancer management;Johnson;J. Clin. Oncol.,2014
2. A review of treatment in non-small-cell lung cancer;Pallis;Eur. Oncol. Haematol.,2012
3. Current challenges in cancer immunotherapy: multimodal approaches to improve efficacy and patient response rates;Sambi;J Oncol,2019
4. Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitors;Tamminga;J. Immunol. Ther. Cancer,2019
5. PD-(L)1 inhibitors and CTLA-4 inhibitors: rationale for combinations and recent data in non-small cell lung cancer;Heist;Am. J. Hematol. Oncol.,2015